Trial Profile
A study comparing F-18]AV-1451 off-target retention in cognitively normal elderly African-Americans and Caucasians
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Oct 2018
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Cognition disorders
- Focus Diagnostic use
- 04 Oct 2018 New trial record